Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1

Giovanni Corsello, Vincenzo Antona, Gregorio Serra, Federico Zara, Clara Giambrone, Luca Lagalla, Maria Piccione, Ettore Piro

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: The aim of this retrospective study was to define clinical and molecular characteristics of a large sample of neurofibromatosis type 1 (NF1) patients, as well as to evaluate mutational spectrum and genotype-phenotype correlation. NF1 is a relatively common neurogenetic disorder (1:2500-1:3000 individuals). It is caused by mutations of the NF1 gene on chromosome 17ql1.2, with autosomal dominant pattern of inheritance and wide phenotypical variability. Café-au-lait spots (CALs), cutaneous and/or subcutaneous neurofibromas (CNFs/SCNFs), skinfold freckling, skeletal abnormalities, Lisch nodules of the iris and increased risk of learning and intellectual disabilities, as well as tumors of the nervous system and other organs are its main clinical features. Methods: The preliminary group collected 168 subjects with clinical suspicion of NF1. They were evaluated following the National Institutes of Health (NIH) criteria for NF1, revised by Gutmann et al. 1997, integrated for 67 of them by molecular testing. According to these references, 112 of 168 patients were diagnosed as NF1. The sample was characterized by an equal sex ratio (57 males, 55 females) and age distribution ranging from 10 days to 60 years of age (mean age, 13 years). Results: A wide spectrum of clinical features has been observed in our patients. Mutational analysis resulted positive in 51 cases (76%). Twenty-four mutations detected in our cohort have not been reported to date. Conclusions: This study may contribute to a better definition of genotypic and phenotypic features of NF1 patients, with respect to further insights into the clinical characterization of the disease. In addition, an amplification of the spectrum of mutations in the NF1 gene has been documented.

Original languageEnglish
Article number45
JournalItalian Journal of Pediatrics
Volume44
Issue number1
DOIs
Publication statusPublished - Apr 4 2018

Fingerprint

Neurofibromatosis 1
Neurofibromatosis 1 Genes
Mutation
Nervous System Neoplasms
Neurofibroma
Inheritance Patterns
Learning Disorders
Age Distribution
Sex Ratio
National Institutes of Health (U.S.)
Genetic Association Studies
Iris
Intellectual Disability
Retrospective Studies
Chromosomes
Skin

Keywords

  • Genotype-phenotype correlation
  • New mutation
  • NF1 gene
  • NF1 microdeletion syndrome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1. / Corsello, Giovanni; Antona, Vincenzo; Serra, Gregorio; Zara, Federico; Giambrone, Clara; Lagalla, Luca; Piccione, Maria; Piro, Ettore.

In: Italian Journal of Pediatrics, Vol. 44, No. 1, 45, 04.04.2018.

Research output: Contribution to journalArticle

Corsello, Giovanni ; Antona, Vincenzo ; Serra, Gregorio ; Zara, Federico ; Giambrone, Clara ; Lagalla, Luca ; Piccione, Maria ; Piro, Ettore. / Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1. In: Italian Journal of Pediatrics. 2018 ; Vol. 44, No. 1.
@article{c18fca9fe6d94ceda8dc870de50d9d4a,
title = "Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1",
abstract = "Background: The aim of this retrospective study was to define clinical and molecular characteristics of a large sample of neurofibromatosis type 1 (NF1) patients, as well as to evaluate mutational spectrum and genotype-phenotype correlation. NF1 is a relatively common neurogenetic disorder (1:2500-1:3000 individuals). It is caused by mutations of the NF1 gene on chromosome 17ql1.2, with autosomal dominant pattern of inheritance and wide phenotypical variability. Caf{\'e}-au-lait spots (CALs), cutaneous and/or subcutaneous neurofibromas (CNFs/SCNFs), skinfold freckling, skeletal abnormalities, Lisch nodules of the iris and increased risk of learning and intellectual disabilities, as well as tumors of the nervous system and other organs are its main clinical features. Methods: The preliminary group collected 168 subjects with clinical suspicion of NF1. They were evaluated following the National Institutes of Health (NIH) criteria for NF1, revised by Gutmann et al. 1997, integrated for 67 of them by molecular testing. According to these references, 112 of 168 patients were diagnosed as NF1. The sample was characterized by an equal sex ratio (57 males, 55 females) and age distribution ranging from 10 days to 60 years of age (mean age, 13 years). Results: A wide spectrum of clinical features has been observed in our patients. Mutational analysis resulted positive in 51 cases (76{\%}). Twenty-four mutations detected in our cohort have not been reported to date. Conclusions: This study may contribute to a better definition of genotypic and phenotypic features of NF1 patients, with respect to further insights into the clinical characterization of the disease. In addition, an amplification of the spectrum of mutations in the NF1 gene has been documented.",
keywords = "Genotype-phenotype correlation, New mutation, NF1 gene, NF1 microdeletion syndrome",
author = "Giovanni Corsello and Vincenzo Antona and Gregorio Serra and Federico Zara and Clara Giambrone and Luca Lagalla and Maria Piccione and Ettore Piro",
year = "2018",
month = "4",
day = "4",
doi = "10.1186/s13052-018-0483-z",
language = "English",
volume = "44",
journal = "Italian Journal of Pediatrics",
issn = "1720-8424",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1

AU - Corsello, Giovanni

AU - Antona, Vincenzo

AU - Serra, Gregorio

AU - Zara, Federico

AU - Giambrone, Clara

AU - Lagalla, Luca

AU - Piccione, Maria

AU - Piro, Ettore

PY - 2018/4/4

Y1 - 2018/4/4

N2 - Background: The aim of this retrospective study was to define clinical and molecular characteristics of a large sample of neurofibromatosis type 1 (NF1) patients, as well as to evaluate mutational spectrum and genotype-phenotype correlation. NF1 is a relatively common neurogenetic disorder (1:2500-1:3000 individuals). It is caused by mutations of the NF1 gene on chromosome 17ql1.2, with autosomal dominant pattern of inheritance and wide phenotypical variability. Café-au-lait spots (CALs), cutaneous and/or subcutaneous neurofibromas (CNFs/SCNFs), skinfold freckling, skeletal abnormalities, Lisch nodules of the iris and increased risk of learning and intellectual disabilities, as well as tumors of the nervous system and other organs are its main clinical features. Methods: The preliminary group collected 168 subjects with clinical suspicion of NF1. They were evaluated following the National Institutes of Health (NIH) criteria for NF1, revised by Gutmann et al. 1997, integrated for 67 of them by molecular testing. According to these references, 112 of 168 patients were diagnosed as NF1. The sample was characterized by an equal sex ratio (57 males, 55 females) and age distribution ranging from 10 days to 60 years of age (mean age, 13 years). Results: A wide spectrum of clinical features has been observed in our patients. Mutational analysis resulted positive in 51 cases (76%). Twenty-four mutations detected in our cohort have not been reported to date. Conclusions: This study may contribute to a better definition of genotypic and phenotypic features of NF1 patients, with respect to further insights into the clinical characterization of the disease. In addition, an amplification of the spectrum of mutations in the NF1 gene has been documented.

AB - Background: The aim of this retrospective study was to define clinical and molecular characteristics of a large sample of neurofibromatosis type 1 (NF1) patients, as well as to evaluate mutational spectrum and genotype-phenotype correlation. NF1 is a relatively common neurogenetic disorder (1:2500-1:3000 individuals). It is caused by mutations of the NF1 gene on chromosome 17ql1.2, with autosomal dominant pattern of inheritance and wide phenotypical variability. Café-au-lait spots (CALs), cutaneous and/or subcutaneous neurofibromas (CNFs/SCNFs), skinfold freckling, skeletal abnormalities, Lisch nodules of the iris and increased risk of learning and intellectual disabilities, as well as tumors of the nervous system and other organs are its main clinical features. Methods: The preliminary group collected 168 subjects with clinical suspicion of NF1. They were evaluated following the National Institutes of Health (NIH) criteria for NF1, revised by Gutmann et al. 1997, integrated for 67 of them by molecular testing. According to these references, 112 of 168 patients were diagnosed as NF1. The sample was characterized by an equal sex ratio (57 males, 55 females) and age distribution ranging from 10 days to 60 years of age (mean age, 13 years). Results: A wide spectrum of clinical features has been observed in our patients. Mutational analysis resulted positive in 51 cases (76%). Twenty-four mutations detected in our cohort have not been reported to date. Conclusions: This study may contribute to a better definition of genotypic and phenotypic features of NF1 patients, with respect to further insights into the clinical characterization of the disease. In addition, an amplification of the spectrum of mutations in the NF1 gene has been documented.

KW - Genotype-phenotype correlation

KW - New mutation

KW - NF1 gene

KW - NF1 microdeletion syndrome

UR - http://www.scopus.com/inward/record.url?scp=85044968071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044968071&partnerID=8YFLogxK

U2 - 10.1186/s13052-018-0483-z

DO - 10.1186/s13052-018-0483-z

M3 - Article

C2 - 29618358

AN - SCOPUS:85044968071

VL - 44

JO - Italian Journal of Pediatrics

JF - Italian Journal of Pediatrics

SN - 1720-8424

IS - 1

M1 - 45

ER -